The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations. For more information on pursuing or mitigating IPR-related import restrictions, please contact attorney Lee Sandler via email or at (305) 894-1000.
Adalimumab – new IPR infringement complaint filed on adalimumab, processes for manufacturing or relating to the same, and products containing the same (complainants AbbVie Inc., AbbVie Biotechnology Ltd., and AbbVie Operations Singapore Pte. Ltd.; proposed respondents located in Germany, Iceland, Israel, Switzerland, and the U.S.)
In vitro products – Jan. 14 deadline for comments on public interest issues raised by recommendation to issue a limited exclusion order and a cease and desist order following initial determination of IPR infringement in investigation 337-TA-1196 of in vitro fertilization products, components thereof, and products containing the same
LED products – issuance of limited exclusion order and cease and desist order in patent infringement investigation 337-TA-1213 of light-emitting diode products, fixtures, and components thereof
Massage devices – issuance of general exclusion order and cease and desist order in patent infringement investigation 337-TA-1206 of percussive massage devices
Skin rejuvenation devices – termination without import restrictions of patent infringement investigation 337-TA-1262 of skin rejuvenation resurfacing devices, components thereof, and products containing the same based on a settlement agreement
Storage and retrieval systems – Jan. 14 deadline for comments on public interest issues raised by recommendation to issue a limited exclusion order following initial determination of IPR infringement in investigation 337-TA-1228 of automated storage and retrieval systems, robots, and components thereof
Vehicle control systems – termination without import restrictions of patent infringement investigation 337-TA-1235 of vehicle control systems, vehicles containing the same, and components thereof based on a settlement agreement
Copyright © 2025 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.